JVMTX | PMVEX | JVMTX / PMVEX | |
Total Expense Ratio | 1.00 | 1.23 | 81% |
Annual Report Gross Expense Ratio | 1.11 | 25.08 | 4% |
Fund Existence | 12 years | 8 years | - |
Gain YTD | 8.919 | 5.327 | 167% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.6B | 163M | 14,479% |
Annual Yield % from dividends | 0.64 | 1.29 | 50% |
Returns for 1 year | 0.62 | 8.41 | 7% |
Returns for 3 years | 11.58 | 17.77 | 65% |
Returns for 5 years | 49.36 | 88.85 | 56% |
Returns for 10 years | 43.95 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HGHSX | 37.13 | 0.56 | +1.53% |
Hartford Healthcare R4 | |||
FCGYX | 20.34 | 0.03 | +0.15% |
NYLI PineStone Global Equity Class C | |||
SUVAX | 12.58 | -0.05 | -0.40% |
PGIM Quant Solutions Large-Cap Val A | |||
LCGRX | 24.80 | -0.10 | -0.40% |
Loomis Sayles Small Cap Growth Retail | |||
PRVIX | 53.38 | -0.23 | -0.43% |
T. Rowe Price Small-Cap Value I |